Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
02/10/2011 | US20110033485 Analogues of glycolipids useful as immunoadjuvants |
02/10/2011 | US20110033484 LprG AS A CHAPERONE OF IMMUNE ADJUVANTS |
02/10/2011 | US20110033402 Solubilized benzoyl small molecule |
02/10/2011 | DE102009038512A1 Use of formulation comprising a substance, polyether polyol, preferably e.g. polyethylene glycol, dimethyl isosorbide, triglyceride, alcohol, preferably ethanol or isopropanol and residual water, to treat nail and/or nail bed disease |
02/10/2011 | CA2805127A1 Process for preparation of over-the-counter gelatin or pectin-based drug delivery |
02/10/2011 | CA2770149A1 Controlled release formulations of lipocalin muteins |
02/10/2011 | CA2770077A1 Formulations comprising linaclotide |
02/10/2011 | CA2770042A1 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
02/10/2011 | CA2769882A1 Targeting of bone marrow neovasculature |
02/10/2011 | CA2769326A1 Blood coagulation protein conjugates |
02/10/2011 | CA2769221A1 Concentrated polypeptide formulations with reduced viscosity |
02/09/2011 | EP2281843A1 Antibodies that immunospecifically bind to blys |
02/09/2011 | EP2281842A1 Antibodies that immunospecifically bind to BLyS |
02/09/2011 | EP2281578A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
02/09/2011 | EP2281577A2 Drug conjugate composition |
02/09/2011 | EP2281576A1 Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition |
02/09/2011 | EP2281573A2 Influenza vaccine formulations for intradermal delivery |
02/09/2011 | EP2281554A1 Eye drop composition comprising ketotifen |
02/09/2011 | EP2281553A2 Pharmaceutical composition and method for treating hypogonadism |
02/09/2011 | EP2281006A1 Cross-linkers and their uses |
02/09/2011 | EP2281004A1 Prostate specific membrane antigen antibodies and antigen binding fragments |
02/09/2011 | EP2280734A2 Factor ix conjugates with extended half-lives |
02/09/2011 | EP2280731A1 Anti human immunodeficiency antibodies and uses thereof |
02/09/2011 | EP2280727A1 Vaccine compositions for the treatment of dengue fever and uses thereof |
02/09/2011 | EP2280712A2 Fluocinolone formulations in a biodegradable polymer carrier |
02/09/2011 | EP2280688A1 Aqueous pharmaceutical formulation |
02/09/2011 | EP1819227B1 Pharmaceutical formulation of decitabine |
02/09/2011 | EP1773353B1 Formulations for parenteral administration of (e)-2,6-dialkoxystryryl 4-substituted benzylsulfones |
02/09/2011 | EP1585538B1 Non-hypertensive pegylated hemoglobins and methods of preparation thereof |
02/09/2011 | EP1559426B1 Percutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one |
02/09/2011 | EP1539114B1 Film coating for tablets and caplets |
02/09/2011 | EP1459738B1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties |
02/09/2011 | EP1381385B1 Insulin preparations, which do not contain any zinc or only a small quantity of zinc and which have an improved stability |
02/09/2011 | CN1960716B Oral preparations and process for production thereof |
02/09/2011 | CN1925873B Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
02/09/2011 | CN1859926B Polymer encapsulation of adenoviruses |
02/09/2011 | CN1547464B Prolonged release bioadhesive therapeutic systems |
02/09/2011 | CN101970498A Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
02/09/2011 | CN101970478A Modulation of sirpalphalpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
02/09/2011 | CN101970012A Drug carriers |
02/09/2011 | CN101970011A Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
02/09/2011 | CN101970010A Liquid formulation of fsh |
02/09/2011 | CN101970009A Nicorandil carriers with enhanced stability |
02/09/2011 | CN101969980A Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and/or their cancerous counterpart |
02/09/2011 | CN101969963A Pharmaceutical composition and combined agent |
02/09/2011 | CN101969958A Vitamin d compositions and method of administration to a human being |
02/09/2011 | CN101969956A Corticosteroid compositions |
02/09/2011 | CN101969939A Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
02/09/2011 | CN101969930A Misuse preventative, controlled release formulation |
02/09/2011 | CN101969929A Powdered protein compositions and methods of making same |
02/09/2011 | CN101969924A Pharmaceutical composition with gelling properties containing a tyrosine derivative |
02/09/2011 | CN101967232A Preparation method of croscarmellose sodium |
02/09/2011 | CN101967196A Interferon fusion protein, preparation thereof and application thereof |
02/09/2011 | CN101967195A Thrombolysis-targeting fusion protein mAnxB1ScuPA, structure and application thereof |
02/09/2011 | CN101967192A Fusion protein of anti-CD20 antibody fragment and lidamycin (LDM) as well as preparation method and application thereof |
02/09/2011 | CN101967191A Preparation method of HLA-G (Human Leukocyte Antigen G) antibody and application of HLA-G antibody in medicine |
02/09/2011 | CN101966344A Hollow core-shell nanometer mesoporous medicament carrying system with magnetism and luminescent performance, preparation method and application thereof |
02/09/2011 | CN101966340A Method for producing florfenicol soluble powder |
02/09/2011 | CN101966339A Thermoplastic elastomer styrene-isoprene-styrene (SIS) framework material extruded and coated by extruder |
02/09/2011 | CN101966334A Application of lecithin superoxide dismutase composite in preparation of medicines for treating and/or preventing cardiac ischemic injury |
02/09/2011 | CN101966244A Preparation method of sugar-free type anti-cold and antidotal granule |
02/09/2011 | CN101966208A Medicament for treating tristimania and preparation method thereof |
02/09/2011 | CN101966203A Study and application of release technique of effective compound group of traditional Chinese Medical prescription |
02/09/2011 | CN101966202A Fishy smell-free multi-dimensional fish oil emulsion composition and preparation method thereof |
02/09/2011 | CN101966196A Formula of catalpol-puerarin injection and powder and preparation method |
02/09/2011 | CN101966186A Composition for treating chicken escherichia coli infection and preparation method thereof |
02/09/2011 | CN101966185A Composition for treating chronic respiratory infection of chicken and preparation method thereof |
02/09/2011 | CN101966171A Hydrosoluble reduced enzyme Q10 composition and preparation method thereof |
02/09/2011 | CN101966169A Compound immunopotentiator for sea cucumber and preparation method thereof |
02/09/2011 | CN101966167A Melatonin soft capsules and preparation method thereof |
02/09/2011 | CN101966166A Capsule containing cefixime liposome and preparation method thereof |
02/09/2011 | CN101966165A Solid effervescent mixture for the oral absorption |
02/09/2011 | CN101966164A Nifedipine sustained release tablet |
02/09/2011 | CN101966163A Febuxostat dispersible tablet and preparation method thereof |
02/09/2011 | CN101966162A Insulin buccal tablets and preparation method thereof |
02/09/2011 | CN101966161A Rabeprazole sodium liposome enteric-coated tablets |
02/09/2011 | CN101966160A Dispersible tablet containing cefixime liposome and preparation method thereof |
02/09/2011 | CN101966159A Tablet containing cefixime liposome and preparation method thereof |
02/09/2011 | CN101966157A Decitabine sustained release microsphere and preparation method thereof |
02/09/2011 | CN101966156A Azithromycin for suspension and preparation method thereof |
02/09/2011 | CN101966155A Preparation of hollow liquid crystal microspheres of psoralen |
02/09/2011 | CN101966154A Granular formulation containing cefixime liposomes and preparation method thereof |
02/09/2011 | CN101966153A Preparation process of As2O3/Fe3O4 composite nano-particles |
02/09/2011 | CN101966152A Cefpiramide composite |
02/09/2011 | CN101966151A Trimipramine maleate liposome solid preparation |
02/09/2011 | CN101966149A Preparation of medicament fat emulsion for treating cerebral infarction |
02/09/2011 | CN101966147A Ibuprofen injection composite and preparation method thereof |
02/09/2011 | CN101966146A Medicinal composition solution and preparation method and use thereof |
02/09/2011 | CN101966144A Preparation and application of olopatadine in-situ gel |
02/09/2011 | CN101966143A Preparation and application of gatifloxacin temperature and pH sensitive ophthalmic gel |
02/09/2011 | CN101965974A Compositions and products containing enantiomeric equol, and methods for their making |
02/09/2011 | CN101647773B Octreotide acetate injection |
02/09/2011 | CN101638828B Method for preparing amphiphilic composite nanometer film by using high pressure electrostatic spinning |
02/09/2011 | CN101606916B Pharmaceutical formulations of modafinil and its uses |
02/09/2011 | CN101507817B High-safety polysorbate-80 for injection and preparation method thereof |
02/09/2011 | CN101502655B Method for preparing pH-sensitive photocrosslinkable hydrogel |
02/09/2011 | CN101427992B Clopidogrel hydrobromate preparation and method of producing the same |
02/09/2011 | CN101422500B Immunoenhancement regulator of pig blue-ear disease vaccine and use thereof |
02/09/2011 | CN101411879B SiO2/Au nano material with nucleocapsid structure-biological protein medicament complex and preparation method thereof |
02/09/2011 | CN101361976B Hyaluronic acid modified polu-cyano acrylic acid alkyl ester nano granules and preparation method and use thereof |